Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2 - Watanabe, H; Morimoto, T; Ogita, M; STOPDAPT-2 Investigators (Cardiovasc Interv Ther, 2021)